581 related articles for article (PubMed ID: 15489090)
1. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
Ezekowitz J; McAlister FA; Humphries KH; Norris CM; Tonelli M; Ghali WA; Knudtson ML;
J Am Coll Cardiol; 2004 Oct; 44(8):1587-92. PubMed ID: 15489090
[TBL] [Abstract][Full Text] [Related]
2. Renal insufficiency as an independent predictor of mortality among women with heart failure.
Bibbins-Domingo K; Lin F; Vittinghoff E; Barrett-Connor E; Grady D; Shlipak MG
J Am Coll Cardiol; 2004 Oct; 44(8):1593-600. PubMed ID: 15489091
[TBL] [Abstract][Full Text] [Related]
3. Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.
McAlister FA; Ghali WA; Gong Y; Fang J; Armstrong PW; Tu JV
Circulation; 2006 Jun; 113(22):2572-8. PubMed ID: 16735672
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia.
Keough-Ryan TM; Kiberd BA; Dipchand CS; Cox JL; Rose CL; Thompson KJ; Clase CM
Am J Kidney Dis; 2005 Nov; 46(5):845-55. PubMed ID: 16253724
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
[TBL] [Abstract][Full Text] [Related]
6. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
Shah R; Wang Y; Foody JM
Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
[TBL] [Abstract][Full Text] [Related]
7. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
Masoudi FA; Rathore SS; Wang Y; Havranek EP; Curtis JP; Foody JM; Krumholz HM
Circulation; 2004 Aug; 110(6):724-31. PubMed ID: 15289383
[TBL] [Abstract][Full Text] [Related]
8. Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study.
Bradshaw PJ; Jamrozik K; Gilfillan I; Thompson PL
Am Heart J; 2004 Jun; 147(6):1047-53. PubMed ID: 15199354
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.
Granmyr J; Ball P; Curran S; Wang L
Aust J Rural Health; 2007 Aug; 15(4):241-6. PubMed ID: 17617087
[TBL] [Abstract][Full Text] [Related]
10. Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy.
Makowsky MJ; McAlister FA; Galbraith PD; Southern DA; Ghali WA; Knudtson ML; Tsuyuki RT;
Am Heart J; 2008 Feb; 155(2):348-55. PubMed ID: 18215607
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of renal dysfunction in patients with chronic heart failure: 12-month follow-up.
Roik M; Starczewska MH; Stawicki S; Solarska-Półchłopek A; Warszawik O; Oreziak A; Kochanowski J; Kosior D; Opolski G
Kardiol Pol; 2006 Jul; 64(7):704-11; discussion 712. PubMed ID: 16886127
[TBL] [Abstract][Full Text] [Related]
12. A review of heart failure management in the elderly population.
Cheng JW; Nayar M
Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
[TBL] [Abstract][Full Text] [Related]
13. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
Feringa HH; Bax JJ; Karagiannis SE; Noordzij P; van Domburg R; Klein J; Poldermans D
Arch Gerontol Geriatr; 2009; 48(1):116-20. PubMed ID: 18177954
[TBL] [Abstract][Full Text] [Related]
14. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
Turley AJ; Roberts AP; Morley R; Thornley AR; Owens WA; de Belder MA
Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766
[TBL] [Abstract][Full Text] [Related]
15. Statin use and survival outcomes in elderly patients with heart failure.
Ray JG; Gong Y; Sykora K; Tu JV
Arch Intern Med; 2005 Jan; 165(1):62-7. PubMed ID: 15642876
[TBL] [Abstract][Full Text] [Related]
16. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
17. Aspirin use in older patients with heart failure and coronary artery disease: national prescription patterns and relationship with outcomes.
Masoudi FA; Wolfe P; Havranek EP; Rathore SS; Foody JM; Krumholz HM
J Am Coll Cardiol; 2005 Sep; 46(6):955-62. PubMed ID: 16168275
[TBL] [Abstract][Full Text] [Related]
18. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
[TBL] [Abstract][Full Text] [Related]
19. Long-term adherence with cardiovascular drug regimens.
Kulkarni SP; Alexander KP; Lytle B; Heiss G; Peterson ED
Am Heart J; 2006 Jan; 151(1):185-91. PubMed ID: 16368315
[TBL] [Abstract][Full Text] [Related]
20. Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and β-blockers after coronary artery bypass graft surgery.
Kalavrouziotis D; Buth KJ; Cox JL; Baskett RJ
Am Heart J; 2011 Nov; 162(5):836-43. PubMed ID: 22093199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
